TLR9 and cutaneous leishmaniasis: Finally, Cpg ODN improved the clinical outcome of immunized rhesus macaques infected with L. major, supporting the hypothesis that TLR9 stimulation might improve the efficacy of vaccination against cutaneous leishmaniasis [92].